CIENCIASMEDICASNEWS: Medical News | Medical Articles: FDA Clearance for Latest CO Breath Analysis Monitor

viernes, 23 de agosto de 2019

Medical News | Medical Articles: FDA Clearance for Latest CO Breath Analysis Monitor

	August 23, 2019
	Respiratory Diseases
	The latest respiratory diseases news from News Medical

FDA Clearance for Latest CO Breath Analysis Monitor

Unlike traditional methods, breath analysis using exhaled carbon monoxide is non-invasive with instant results, saving time in critical situations. Breath samples can be taken via a low-cost mouthpiece allowing for point-of-care CO checking for mass casualties, aiding the decision of whether or not a patient needs to be treated at hospital.

Find Out More

			Removing asbestos from schools likely to increase cases of mesothelioma Removing asbestos from every school in the UK could result in more deaths from mesothelioma than if the asbestos was left in place, claims expert.

			Discovery of distinct lung cancer pathways could help future patients Known for its poor prognosis, lung adenocarcinoma is the most common type of lung cancer, responsible for about 4 of 10 diagnoses, according to the National Cancer Institute.

	Tuberculosis still looms large over a fourth of the world’s people A new Danish study concludes that a quarter of the people on earth have the tuberculosis bacillus within their bodies. This disease preys on over 10 million people annually, and kills 2 million a year. It is Number 1 on the list of killer diseases, far above AIDS and other infections.

	Study uncovers cause of asthmatic lung spasms Researchers at Rutgers and other institutions have discovered how muscle contraction (bronchospasm) in the airway, which cause breathing difficulty in people with asthma, occur by creating a microdevice that mimics the behavior of the human airways.

	Study finds specific direct targets for lung cancer treatment A team of researchers at the Salk Institute has found two therapeutic targets for the deadly type of lung cancer, non-small-cell lung carcinomas (NSCLCs), which accounts for 85 percent of all lung cancer cases. They believe that the breakthrough discovery could pave the way for the development of new treatments for a majority of lung cancer patients.